Search

everythinglearnresearchcommunity

for

Search:↓

Confocal Laser Scanning Microscopy (CLSM) is a useful tool for studying how drugs interact with skin and diagnosing skin disorders, despite some limitations.

The technique accurately identifies and evaluates hair follicle structures in skin.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

A rare genetic variant linked to skin cysts was found in blood DNA, suggesting its role in cyst formation.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

A new molecule was found to be a safe and effective skin lightener and anti-aging product.

Folliculotropic mycosis fungoides can affect the central nervous system in advanced stages.

Overexpressing Merkel cell virus proteins in human hair follicles can create clusters of cells that resemble Merkel cell cancer.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

SIG-1451 could be a promising new treatment for atopic dermatitis.

CLK1 is needed for skin cells to become epidermal cells but not sebocytes.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Alpha-MSH affects mitochondrial function, and MC1R mutations may increase skin aging.

M1 homeopathic complex may help slow melanoma cell growth.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

A new one-step test can quickly identify skin cancer during surgery.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Dynamet Technology won an award for its advanced titanium technology.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

pbn-STAC effectively finds strategies for cellular reprogramming using deep reinforcement learning.

Combining LFQS and IPL is more effective and faster for treating melasma than LFQS alone.

The digital system for measuring melasma shows promise but needs more development for better accuracy and automation.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.